Substance use treatment; Detoxification; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children; Hospital inpatient/24-hour hospital inpatient; Outpatient; Hospital inpatient detoxification; Hospital inpatient treatment; Intensive outpatient treatment; General Hospital (including VA hospital); Buprenorphine used in Treatment; Naltrexone used in Treatment; In-network prescribing entity; Other contracted prescribing entity; This facility administers/prescribes medication for alcohol use disorder; In-network prescribing entity; Other contracted prescribing entity; Buprenorphine detoxification; Buprenorphine maintenance; Buprenorphine maintenance for predetermined time; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine/clonidine detoxification; Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; 12-step facilitation; Private non-profit organization; State department of health; The Joint Commission; IHS/Tribal/Urban (ITU) funds; Medicare; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; STD testing; TB screening; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV); Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge; Self-help groups; Alcohol Detoxification; Benzodiazepines Detoxification; Opioids detoxification; Medication routinely used during detoxification; Substance use disorder education; Group counseling; Smoking not permitted; Adults; Young adults; Female; Male; Sign language services for the deaf and hard of hearing; Vaping not permitted; Case management service; Mental health services; Suicide prevention services